Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
07/2009
07/29/2009CN101492496A A method for identification, isolation and production of antigens to a specific pathogen
07/29/2009CN101491670A Method for treating cardiovascular disease using nervous regulation protein and composite
07/29/2009CN100519751C Optimization of cell for endogenous gene activation
07/29/2009CN100519735C Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria
07/29/2009CN100519584C Antibodies against fibroblast growth factor 23
07/29/2009CN100519582C Insulin and pancreatin coproduction technique
07/29/2009CN100519581C Interferon-beta composite
07/29/2009CN100519580C Angiogenin mutant as agonist, and its preparing method
07/29/2009CN100519579C Method for producing algae toxin immune affinity chromatographic column and use method thereof
07/29/2009CN100519578C White candidas transcription factor gene and its use
07/29/2009CN100519577C Recombined diphtheria toxin, preparation method, and application
07/29/2009CN100518823C Hapten-carrier conjugates and uses thereof
07/29/2009CN100518819C Medical components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components
07/28/2009US7566822 Plants and seeds of corn variety CV256816
07/28/2009US7566816 Generation of plants with altered oil content
07/28/2009US7566777 Genes encoding hormone and lytic peptides
07/28/2009US7566776 Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
07/28/2009US7566774 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
07/28/2009US7566769 Pure polypeptide containing a fragment capable of binding to and inducing apoptosis in a carcinoma cell; Tumor Necrosis Factor Related ligand "TRELL; gene therapy to treat tumors, autoimmune and inflammatory diseases or inherited genetic disorders
07/28/2009US7566768 Promyostatin peptides and methods of using same
07/28/2009US7566767 Synthetic peptides and methods of use for autoimmune disease therapies
07/28/2009US7566766 Use of phage display libraries in a screening assay in order to determine the identity of peptides sequences which enhance the delivery of the bacteriophage through tissue, such as epithelial cells lining the lumen of gastrointestinal tract
07/28/2009US7566764 Truncated BARD1 protein, and its diagnostic and therapeutic uses
07/28/2009US7566741 Methods of inhibiting osteoclast activity
07/28/2009US7566697 chemically ligating two oligopeptides, a first oligopeptide thioester having an acidic C-terminal amino acid, having a thioester group, a side chain, side chain protecting group( phenylacryl ester), prevents rearrangements between atoms of the side chain and thioester, with 2nd oligopeptide
07/28/2009US7566695 Multimeric apoprotein agonists
07/28/2009US7566694 Anti-pathogen treatments
07/28/2009US7566693 Elastin protective polyphenolics and methods of using the same
07/28/2009US7566566 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins
07/28/2009US7566560 Polypeptides and expression vectors host cell and transgenic plants with nucleic acid and stress resistance; antifungal agent
07/28/2009US7566557 Genetic engineering; transketolase ; Corynebacterium or Brevibacterium; developed to produce and secrete large amounts of one or more desired fine chemicals
07/28/2009US7566552 Protection against environmental toxicity through manipulation of the processing of messenger RNA precursors
07/28/2009US7566549 Using hapten derivatives for the preparation of antigens, antibodies and reagents for use detecting lysergic acid diethylamide (LSD) in samples; hallucinogen
07/28/2009US7566547 Gene 763 of phytopathogenic fungus Magnaporthe grisea and use thereof for identifying fungicidal compounds
07/28/2009US7566545 Decreasing blood glucose levels in an animal or for preventing or delaying the onset of a rise in blood glucose levels; improving insulin sensitivity in an animal or for preventing or delaying the onset of insulin resistance; diabetes obesity
07/28/2009US7566540 Monoclonal antibody which agglutinates E. coli having the CS4-CFA/I family protein
07/28/2009US7566536 WNT-regulated cytokine-like polypeptide and nucleic acids encoding same
07/28/2009US7566535 Enhanced oligonucleotide-mediated nucleic acid sequence alteration
07/28/2009US7566458 Influenza hemagglutinin and neuraminidase variants
07/28/2009US7566457 Proteins for use as vaccine to prevent dengue virus infection; immunotherapy; high serotype-specificity to be used in humans
07/28/2009US7566456 Allergen vaccine proteins for the treatment and prevention of allergic diseases
07/28/2009US7566455 Vaccine with a component of a ubiquitin-ligase (E3) enzyme; regulation of gene expression, regulation of the cell-cycle, modification of cell surface receptors, biogenesis of ribosomes, and DNA repair
07/28/2009US7566452 Treating cancer using antagonists to the endothelin B receptor (ETB) or inactive mimic forms of endothelin-1; melanoma
07/28/2009US7566449 Method and composition for inhibition of angiogenesis using antagonists based on MMP-9 and β1 integrins
07/28/2009US7566447 Biocides
07/28/2009US7566446 Wound healing and treatment of fibrosis
07/28/2009US7566420 Methods, kits and compositions pertaining to combination oligomers and libraries for their preparation
07/28/2009CA2435159C A method of preparing a collagen sponge
07/28/2009CA2316447C Rantes mutants and therapeutic applications thereof
07/28/2009CA2178592C Long-acting injection suspensions and a process for their preparation
07/28/2009CA2148369C Actinobacillus pleuropneumoniae outer membrane lipoprotein a and uses thereof
07/23/2009WO2009091826A2 Compositions and methods related to a human cd19-specific chimeric antigen receptor (h-car)
07/23/2009WO2009091341A1 Novel peptides and protein and uses thereof
07/23/2009WO2009091053A1 Crystal production method, frozen crystal production method, crystal, crystal structure analysis method, crystallization screening method, and crystallization screening apparatus
07/23/2009WO2009091023A1 Composition and method for diagnosis or detection of gastric cancer
07/23/2009WO2009090933A1 Virus growing in hypoxic cell or virus vector expressing gene therein
07/23/2009WO2009090553A2 Compositions and methods of detecting post-stop peptides
07/23/2009WO2009090512A1 A truncated form of the hiv p17 protein
07/23/2009WO2009090381A2 Glycosyl hydrolase polypeptides
07/23/2009WO2009090379A2 Phenol oxidase polypeptides
07/23/2009WO2009090330A2 Use of protein 8c2 for in vitro diagnosis of mycoplasma pneumoniae infections
07/23/2009WO2009090268A1 Peptide mimetics
07/23/2009WO2009090227A2 PEPTIDES HAVING BINDING AFFINITY TO AN ANTIBODY WHICH RECOGNIZES AN EPITOPE ON AN α1 LOOP 2 OR β2 LOOP 1 OF AN ADRENORECEPTOR
07/23/2009WO2009090175A1 Vaccine comprising a ribosomal protein extract (rpe) and optionally a th1-promoting adjuvant
07/23/2009WO2009090168A1 Anti-bacterial compositions
07/23/2009WO2009090056A2 Purification of non-glycosylated proteins
07/23/2009WO2009090049A1 Peptides for the specific binding and regulation of protein targets
07/23/2009WO2009089678A1 Scirr10 neurotrophic factor, its receptor and uses thereof
07/23/2009WO2009064118A3 Polypeptide inducing dwarfism of plants, polynucleotide coding the polypeptide, and those use
07/23/2009WO2009058734A4 Compounds exhibiting glucagon antagonist and glp-1 agonist activity
07/23/2009WO2009056566A3 Plants having enhanced yield-related traits and a method for making the same
07/23/2009WO2009054878A3 Compositions and methods for the treatment of neoplasia
07/23/2009WO2009053535A3 Peptide vaccine for influenza virus
07/23/2009WO2009050453A3 Breast cancer associated antigen
07/23/2009WO2009048658A3 Optimized dengue virus entry inhibitory peptide (dn81)
07/23/2009WO2009027063A3 MUTANT DOUBLE CYCLIZED RECEPTOR PEPTIDES INHIBITING β1-ADRENOCEPTOR ANTIBODIES
07/23/2009WO2009014782A3 Improved production and in vivo assembly of soluble recombinant icosahedral virus-like particles
07/23/2009WO2009014462A8 Methods and polynucleotides for improving plants
07/23/2009WO2008142693A8 Regulation of myelination by nectin-like (necl) molecules
07/23/2009WO2008136736A8 Immunoregulatory structures from normally occurring proteins
07/23/2009WO2008127179A8 Fusion protein vaccine
07/23/2009WO2008118601A3 Radiolabeled affibody molecules
07/23/2009WO2008103043A8 Rgd containing recombinant gelatin
07/23/2009WO2008103042A8 Recombinant xrgd-enriched gelatins having high stability
07/23/2009WO2008103041A8 Recombinant gelatins
07/23/2009WO2008091153A8 A functional r-gene from solanum bulbocastanum
07/23/2009WO2008086386A8 Adenoviral vector-based malaria vaccines
07/23/2009WO2008063113A8 Cell -penetrating peptides and constructs containing them consisting 15-25 amino acids of tumor supressor protein p14arf or p19arf
07/23/2009WO2008041863A8 Novel genes and polypeptides associated with insecticidal activity
07/23/2009WO2007148971A8 Vectors with modified initiation codon for the translation of aav-rep78 useful for production of aav in insect cells
07/23/2009WO2007148970A8 Use of plant chromatin remodeling genes for modulating plant architecture and growth
07/23/2009WO2007142582A8 Fluorescent proteins and genes encoding them
07/23/2009WO2007133153A8 Improved antimicrobial peptides
07/23/2009WO2007125142A8 Antimicrobial linear peptides
07/23/2009WO2007100807A8 Npc1l1 orthologues
07/23/2009WO2007100248A4 Adir related polymorphisms and applications thereof
07/23/2009WO2007096854A8 Compositions and methods for modulating an immune response
07/23/2009WO2007091958A8 Novel antimicrobial peptides and use thereof
07/23/2009WO2007084922A8 Compositions and methods for humanization and optimization of n-glycans in plants
07/23/2009WO2007084364A8 Improved il-12 for expression in mammalian cells